Marco Mina
Marco Mina
HAYA Therapeutics
Verified email at
Cited by
Cited by
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Pan-cancer landscape of aberrant DNA methylation across human tumors
S Saghafinia, M Mina, N Riggi, D Hanahan, G Ciriello
Cell reports 25 (4), 1066-1080. e8, 2018
Semantic similarity analysis of protein data: assessment with biological features and issues
PH Guzzi, M Mina, C Guerra, M Cannataro
Briefings in bioinformatics 13 (5), 569-585, 2012
Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas
GP Way, F Sanchez-Vega, K La, J Armenia, WK Chatila, A Luna, ...
Cell reports 23 (1), 172-180. e3, 2018
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
S Ceccarelli, N Panera, M Mina, D Gnani, C De Stefanis, A Crudele, ...
Oncotarget 6 (39), 41434, 2015
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
M Mina, R Boldrini, A Citti, P Romania, V D'Alicandro, M De Ioris, ...
Oncoimmunology 4 (9), e1019981, 2015
EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains
MC Donaldson-Collier, S Sungalee, M Zufferey, D Tavernari, ...
Nature genetics 51 (3), 517-528, 2019
AlignNemo: a local network alignment method to integrate homology and topology
G Ciriello, M Mina, PH Guzzi, M Cannataro, C Guerra
PloS one 7 (6), e38107, 2012
Conditional selection of genomic alterations dictates cancer evolution and oncogenic dependencies
M Mina, F Raynaud, D Tavernari, E Battistello, S Sungalee, S Saghafinia, ...
Cancer cell 32 (2), 155-168. e6, 2017
The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase
VR Sanghvi, J Leibold, M Mina, P Mohan, M Berishaj, Z Li, MM Miele, ...
Cell 178 (4), 807-819. e21, 2019
PD-L1 is a therapeutic target of the bromodomain inhibitor JQ1 and, combined with HLA class I, a promising prognostic biomarker in neuroblastoma
O Melaiu, M Mina, M Chierici, R Boldrini, G Jurman, P Romania, ...
Clinical Cancer Research 23 (15), 4462-4472, 2017
Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability
F Raynaud, M Mina, D Tavernari, G Ciriello
PLoS genetics 14 (9), e1007669, 2018
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
M Bruand, D Barras, M Mina, E Ghisoni, M Morotti, E Lanitis, N Fahr, ...
Cell reports 36 (3), 2021
Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression
D Tavernari, E Battistello, E Dheilly, AS Petruzzella, M Mina, ...
Cancer discovery 11 (6), 1490-1507, 2021
Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma
E Dheilly, E Battistello, N Katanayeva, S Sungalee, J Michaux, G Duns, ...
Cancer cell 37 (5), 674-689. e12, 2020
Systematic inference and comparison of multi-scale chromatin sub-compartments connects spatial organization to cell phenotypes
Y Liu, L Nanni, S Sungalee, M Zufferey, D Tavernari, M Mina, S Ceri, ...
Nature communications 12 (1), 2439, 2021
A transcribed enhancer dictates mesendoderm specification in pluripotency
M Alexanian, D Maric, SP Jenkinson, M Mina, CE Friedman, CC Ting, ...
Nature communications 8 (1), 1806, 2017
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
WC Cheng, YC Tsui, S Ragusa, VH Koelzer, M Mina, F Franco, H Lšubli, ...
Nature immunology 20 (2), 206-217, 2019
Improving the robustness of local network alignment: design and extensive assessment of a Markov Clustering-based approach
M Mina, P Guzzi
Computational Biology and Bioinformatics, IEEE/ACM Transactions on 11 (3†…, 2014
The system can't perform the operation now. Try again later.
Articles 1–20